Clinical Trial Update: Iguratimod Combined With Tofacitinib in the Treatment of Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the combination of iguratimod with tofacitinib for rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Iguratimod (iguratimod)
• Tofacitinib (tofacitinib)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Rheumatoid Arthritis | Phase 4 | Status: UNKNOWN